Showing 102 of 102on this page. Filters & sort apply to loaded results; URL updates for sharing.102 of 102 on this page
Biogen expanded with Edinburgh AD acquisition
Biogen acquires five AD plants from Ingenious - letsrecycle.com
Biogen acquires five AD plants from Ingenious - Biogen
Eisai and us submit FDA application for AD treatment | Biogen posted on ...
Biogen opens Bryn Pica AD plant in South Wales - letsrecycle.com
Aduhelm go-ahead in AD leaves ICER cold; Biogen touts four-year price ...
UK biogas company Biogen acquires five AD plants from Ingenious
Biogen continues to advance BIIB080 in early AD | Alzheimer Europe
Biogen | ADBA | Anaerobic Digestion & Bioresources Association
FDA Approves New Alzheimer's Drug But Creators Biogen And Eisai Stock ...
Biogen Projects | Photos, videos, logos, illustrations and branding on ...
Biogen präsentiert neue Litifilimab-Phase-2-Daten zu CLE auf der AAD 2
AD and Biogas Industry Awards 2023 winners announced | ADBA | Anaerobic ...
Biogen plans to present its advances in Alzheimer’s and Parkinson’s ...
Biogen drops Alzheimer's drug Aduhelm, ending a 17-year chapter | Reuters
U.S. approval of Biogen Alzheimer's drug sends shares soaring, hailed ...
Biogen adquire a empresa Reata Pharmaceuticals | Atlas da Saúde
Biogen to cut 1,000 jobs as focus turns to Alzheimer's drug Leqembi ...
Biogen on LinkedIn: What are Biosimilars?
US FDA approves Biogen Alzheimer’s drug, hailed as ‘a big day’
U.S. experts to review Biogen drug that could be first new Alzheimer's ...
Biogen beats quarterly estimates as newer drugs drive growth | Reuters
Biogen wasted no time in rolling out a ‘disease awareness’ campaign for ...
Rheumatoid Arthritis (RA) | Biogen
Biogen is buying up an immune drug developer for $1.8 billion
Biogen Q2 2025 slides: Raised guidance, pipeline expansion drive stock ...
Student Programs | Biogen
FDA approves new Biogen Alzheimer's drug aducanumab
Biogen Partners With InnoCare To Keep Up With BTK Inhibitor Leaders in MS
Biogen Case Study
Yes we aducanumab? Biogen/Eisai AD bid gains traction, outlook still ...
Biogen - The Irish Times
Biogen will seek approval of Alzheimer's drug
Biogen picks up Pfizer's Phase 1 therapy for Alzheimer's symptoms in ...
Biogen Magnesium Glycinate For Better Absorption
Biogen модернізує виробничі потужності. Читайте на UKR.NET
Medicamento de Biogen para el Alzheimer, sujeto de investigación del ...
Biogen | Home
Biogen on LinkedIn: Biogen Symposium from AAIC 2020. Watch now!
BIOGEN ALZHEIMER’S NEW DRUG APPROVED EXPLAINED // FDA Approves Biogen ...
Biogen on LinkedIn: Spinal Muscular Atrophy | SMA Disease | Together in SMA
Biotech Company Biogen to Pay $900M to Settle Doctor Kickback ...
Biogen Advances Alzheimer’s Drug on Suggestion of Benefit - Bloomberg
Biogen settles 401(k) lawsuit for $9.75 million | Pensions & Investments
Biogen raises 2024 financial guidance as Leqembi sales pick up - Boston ...
Biogen Surges as New Alzheimer's and Rare-Disease Drugs Drive Profit ...
Biogen Shares Rally on Dual Clinical Breakthroughs
2024 Corporate Responsibility Report | Biogen
Biogen Announces New Global Headquarters at Kendall Common, Cambridge
Code of Business Conduct | Biogen
Innover au service du collectif, c’est une mission chez Biogen - L ...
BIOGEN OMEGA 3 90 + 90 VALUE PACK - PharmacyNet
Biogen desarrolla 25 de sus 29 ensayos clínicos en España: "Los ...
Careers | Biogen
Sobre a Biogen
Biogen Alzheimer drug: What does FDA approval of Biogen’s Alzheimer’s ...
Biogen drops Aduhelm efforts after controversial speedy approval
Alzheimer’s Treatment From Biogen Sent for FDA Approval
POLITICO Pro
US approval of Alzheimer's drug draws fire on treatment's effectiveness ...
U.S. health regulator extends review of Biogen's ALS drug | Reuters
New Alzheimer's drug lecanemab slows disease: study
What is the new Alzheimer's drug approved by the FDA?
Alzheimer’s Society of Ireland 'cautiously optimistic' as US approves ...
Sidewinder secures $137M to advance ‘precision’ ADCs | BioPharma Dive
New Alzheimer's drug slows disease, receives US approval | Daily Sabah
FDA documents show struggle over approval of new Alzheimer's drug from ...
MHRA approves first UK treatment for Friedreich’s ataxia | The Pharmaletter
European Commission approves Biogen’s QALSODY for ALS treatment
Biogen, eisai expand collaboration pact to develop & commercialize a ...
AD/PD™ Webinar: Tau and Neurodegeneration in Alzheimer’s
Biogen: Invisibles • Ads of the World™ | Part of The Clio Network
Biogen:AD药3月开始放量!4月会更棒?医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
U.S. FDA extends review period for Biogen's Alzheimer's drug to June ...
In Quiet Debut, Alzheimer's Drug Rollout Slowed By Questions ...
Biogen’s Investigational Alzheimer’s drug fast-tracked by FDA, ETPharma
Biogen: Invisibles • Ads of the World™ | Part of The Clio Network ...
Eisai-Biogen's Alzheimer's treatment drug receives FDA approval
FDA approves Alzheimer’s drug, the first new therapy for the disease in ...
Alzheimer's disease (AD) is a challenging condition that impacts ...
Why US approval of Alzheimer's drug has divided doctors over its ...
Humor in drug ads? Biogen, 21Grams make it work with gold-winning ...
Biogen's Controversial Alzheimer’s Drug Was Connected to a Patient ...
Biogen, at a Crossroads, Surges on Promising Alzheimer’s Drug ...
FDA approves Biogen-Eisai Alzheimer’s drug, China in talks to make ...
Best Workplaces in Belgium 2026 | Great Place To Work - English
Explainer: What does FDA approval of Biogen's Alzheimer's drug mean for ...
U.S. lawmakers to investigate approval, pricing of Alzheimer's drug ...
Motor Neurone Disease: investigational drug granted accelerated ...
First drug to slow Alzheimer’s disease poised for approval | The ...
FDA approves much-debated Alzheimer’s drug Biogen, 1st in nearly 20 ...
Accedi a congressi, talk di esperti, rinomate riviste scientifiche e ...
Noticias sector farmacéutico - AIMFA
FDA approved controversial Alzheimer’s drug despite objections from staff